Naciye Demirel

Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?

Funda Şimşek, Arzu Kantürk, Osman Yokuş et al. · Therapeutics and Clinical Risk Management · 2014 · 62 citations · Full text

Life Sciences, Hematology, Microbiology +17

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Ahmet Emre Eşkazan, Sevil Sadri, Dilek Keskin et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 25 citations

Medicine, Hematology, Oncology +8

Vancomycin-resistant enterococci colonization and bacteremia in patients with hematological malignancies

Taner Yıldırmak, Funda Şimşek, Arzu Kantürk et al. · The Journal of Infection in Developing Countries · 2014 · 16 citations · Full text

Medicine, Microbiology, Oncology +17

Chanarin-Dorfman syndrome

Semih Kalyon, Yasemin Gökden, Naciye Demirel et al. · The Turkish Journal of Gastroenterology · 2018 · 13 citations · Full text

Life Sciences, Dermatology, Genetics +17

The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies

Funda Şimşek, Arzu Kantürk, D Aydýn et al. · African Health Sciences · 2013 · 11 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17